James M. Krell

James Krell practices at Total Dermatology in Birmingham, Alabama.

James Krell's NPI, 1932133659, was assigned on July 10, 2006. James Krell graduated from Harvard Medical School in 1989. James Krell holds Alabama license 17253.

James Krell's primary practice is Total Dermatology, at 2100 16th S Ave, Birmingham, AL 35205 in Jefferson County.

James Krell's primary practice is Total Dermatology in Birmingham, Alabama. The medical group on file is Total Dermatology. Dmand AI also links James Krell to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where James Krell practices. Vendor and product names are available with a free account.

Dermatology is James Krell's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dmand AI has James Krell's licenses on file in 2 states: Alabama and Georgia.

CMS data shows 5,674 Medicare services from James Krell across 25 procedure codes in 2024, for 1,055 Medicare patients. Medicare paid $181,240 for them. Every service was in an office.

CMS counts 1,055 Medicare patients who saw James Krell in 2024. The largest group is 65 to 74, with 484 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 1% are also on Medicaid. Their average risk score is 1.00, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts James Krell's median patient age at 69, with 42% women.

In 2024, James Krell wrote 3,346 Medicare Part D claims for 1,017 patients. 79% of them were for generic drugs. CMS names the drug for 3,155 of them, across 47 drugs with 11 or more claims each, at $4,894,328 in total drug cost. In 2023, CMS named 2,830 claims across 49 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for James Krell for performance year 2024, reported individually. James Krell accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 2,278 procedures of removal of skin lesions by James Krell, more than 98% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to James Krell in 2016. James Krell's most frequent co-authors are Boni E. Elewski, Mark Gabriel Lebwohl and Bruce E. Strober, MD.

Dmand AI links James Krell to 8 clinical trials, 4 of them phase 3 studies. Conditions studied include Psoriasis, Skin Diseases, Papulosquamous and Alopecia Areata. Eli Lilly and Company sponsors the most, 6. Open Payments lists research payments to James Krell that name 3 trials.

CMS Open Payments shows 2,028 general payments to James Krell from 32 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 78% of the total. Abbvie Inc. paid the most, $373,809. It also lists 17 research payments totaling $42,340 from 2016 to 2024, naming 3 clinical trials.

James Krell graduated from Harvard Medical School in 1989.